| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/14/2004 | CN1157221C Health compsn. |
| 07/14/2004 | CN1157196C Galenic preparation for prevetion and treatment of hepatocarcinoma |
| 07/13/2004 | US6762204 Taxol enhancer compounds |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | US6762170 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 07/13/2004 | CA2375537C Topically applied idebenone-containing agent with protective and regenerative effect |
| 07/08/2004 | WO2004056324A2 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 07/08/2004 | WO2004056322A2 Antibiotics containing borinic acid complexes and methods of use |
| 07/08/2004 | WO2004056319A2 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/08/2004 | WO2004056318A2 Method for treating amyloid disease |
| 07/08/2004 | WO2004056317A2 Compositions for the treatment and prevention of nephropathy |
| 07/08/2004 | WO2004056316A2 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 07/08/2004 | WO2004056315A2 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 07/08/2004 | WO2004056312A2 Immunoglobulin variants and uses thereof |
| 07/08/2004 | WO2004056309A2 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 07/08/2004 | WO2004056307A2 Disease treatment via antimicrobial peptide inhibitors |
| 07/08/2004 | WO2004050018A3 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |
| 07/08/2004 | WO2004045511A3 Non-steroidal farnesoid x receptor modulators |
| 07/08/2004 | WO2004041210A3 Antibacterial agents |
| 07/08/2004 | WO2004041179A3 Scavenger receptor b1 (cla-1) targeting for the treatment of infection, sepsis and inflammation |
| 07/08/2004 | WO2004039308A3 Quinazolinone compositions for regulation of gene expression related to pathological processes |
| 07/08/2004 | WO2004037179A3 Substituted peptides useful in the treatment of alzheimer’s disease |
| 07/08/2004 | WO2004032949A8 Argyrolobium roseum plant extracts for treating diabetes |
| 07/08/2004 | WO2004032882A3 Chemical compounds |
| 07/08/2004 | WO2004032876A9 Deguelin as a chemopreventive agent for lung cancer |
| 07/08/2004 | WO2004028476A3 Artemisinin-derived trioxane dimers |
| 07/08/2004 | WO2004028464A3 Methods and compositions for modification of splicing of pre-mrna |
| 07/08/2004 | WO2004026257A3 Treatment of irritable bowel syndrome and related bowel diseases |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |
| 07/08/2004 | WO2004021995A3 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| 07/08/2004 | WO2004014301A3 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 07/08/2004 | WO2004012657A3 Beta-glucan containing composites, methods for manufacturing and for using such composites |
| 07/08/2004 | US20040133031 Crystal of bicalutamide and production method thereof |
| 07/08/2004 | US20040132826 Modified release compositions of milnacipran |
| 07/08/2004 | US20040132825 Methods of treating cancer with HDAC inhibitors |
| 07/08/2004 | US20040132821 acetyl-L-carnitine and a mixture of polyphenols containing hydroxytyrosol; preventing tissue damage caused by free radicals, diabetic or toxic neuropathies and metabolic disorders of glucose utilization |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132776 Use of benzothiopenes to treat and prevent prostate cancer |
| 07/08/2004 | US20040132750 Acyl guanidine compounds and use thereof |
| 07/08/2004 | US20040132702 luminally active anti-inflammatory or immunosuppressive compound with minimal or no systemic side effects |
| 07/08/2004 | US20040132146 Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B |
| 07/08/2004 | US20040132063 Antisense modulation of microsomal prostaglandin E2 synthase expression |
| 07/08/2004 | US20040132010 Immunogen |
| 07/08/2004 | US20040131681 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 07/08/2004 | US20040131640 Escape mutants of newcastle disease virus as marker vaccines |
| 07/08/2004 | US20040131614 Treatment of pulmonary disorders using TNFalpha inhibitor |
| 07/08/2004 | US20040131548 Ultrasonic diagnosis; microbubbles of gas encapsulated in polymer |
| 07/08/2004 | DE10259619A1 Verwendung einer TRPM8 aktivierenden Substanz zur Tumorbehandlung Using a TRPM8-activating substance for tumor treatment |
| 07/08/2004 | CA2800237A1 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 07/08/2004 | CA2509881A1 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/08/2004 | CA2509645A1 Antibiotics containing borinic acid complexes and methods of use |
| 07/08/2004 | CA2508273A1 Disease treatment via antimicrobial peptide inhibitors |
| 07/08/2004 | CA2507898A1 Immunoglobulin variants and uses thereof |
| 07/07/2004 | EP1435240A2 Solid oral dosage form comprising a combination of methformin and glibenclamide |
| 07/07/2004 | EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 07/07/2004 | EP1434603A2 Method of treatment using ligand-immunogen conjugates |
| 07/07/2004 | EP1434586A1 Estrogen/gestagen combination preparation and application thereof |
| 07/07/2004 | EP1082093B1 Anti-germ attachment - composition |
| 07/07/2004 | EP1047389B1 Dyeing composition for keratinous fibres with direct cationic colouring agent and a non-ionic surfactant |
| 07/07/2004 | CN1511152A N-formyl hydroxylamine compounds as PDF inhibitor |
| 07/07/2004 | CN1156648C Safety device of fluid speed varying apparatus |
| 07/07/2004 | CN1156461C Improved aqueous solubility pharmaceutical formulations |
| 07/07/2004 | CN1156454C Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 07/06/2004 | CA2243715C Method for reducing skin oils and grease |
| 07/01/2004 | WO2004055196A2 Method for identifying risk of breast cancer and treatments thereof |
| 07/01/2004 | WO2004054637A2 Contrast media formulations having improved biological tolerance |
| 07/01/2004 | WO2004054610A1 Vaccine for fish cold-water disease |
| 07/01/2004 | WO2004054516A2 Antagonists for human prolactin |
| 07/01/2004 | WO2004054515A2 Thrombopoietin mimetics |
| 07/01/2004 | WO2004054514A2 C-6 modified indazolylpyrrolotriazines |
| 07/01/2004 | WO2004054513A2 Methods and compositions for treating and preventing ear infections |
| 07/01/2004 | WO2004054512A2 Therapeutic retroviral vectors for gene therapy |
| 07/01/2004 | WO2004054510A2 Method for identifying modulators of human orexin-2 receptor |
| 07/01/2004 | WO2004054507A2 Indolizine compounds |
| 07/01/2004 | WO2004054506A2 Methods and compositions for modulating nf-at transcription factor |
| 07/01/2004 | WO2004054504A2 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | WO2004054502A2 Modulation of tek expression |
| 07/01/2004 | WO2004054497A2 Use of a trpm8-activating substance for the treatment of tumours |
| 07/01/2004 | WO2004034984A3 Cell-seeded tissue-engineered polymers for treatment of intracranial aneurysms |
| 07/01/2004 | WO2004026237A3 Compounds for the treatment of premature ejaculation |
| 07/01/2004 | WO2004021980A3 Compositions and methods for treating niddm and other conditions and disorders associated with ampk regulation |
| 07/01/2004 | WO2004020014A3 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 07/01/2004 | WO2004017921A3 Method for treating inflammatory bowel disease |
| 07/01/2004 | WO2004017905A3 Method and apparatus for noninvasively evaluating endothelial function |
| 07/01/2004 | WO2004014298A3 Composition and method for lowering cholesterol |
| 07/01/2004 | WO2003092582A3 Chimeric ebola virus envelopes and uses therefor |
| 07/01/2004 | US20040127474 Contacting the cell with a ptc agonist in a sufficient amount to inhibit the altered growth state, wherein the ptc agonist is a organic molecule having a molecular weight less than about 750 amu for inhibiting an altered growth state of a cell |
| 07/01/2004 | US20040127427 Ketoamide inhibitors in chronic nerve disease |
| 07/01/2004 | US20040126432 Blood flow enhancer and inflamation reducer, anticholesterol agents and oxidation reduction |
| 07/01/2004 | US20040126414 Methods and compositions for treating and preventing ear infections |
| 07/01/2004 | US20040126373 Administering tumor necrosis factor antibody; restenosis |
| 07/01/2004 | US20040126372 Administering antibodies; respiratory system disorders; cardiovascular disorders; metabolism disorders; anemia; analgesics; liver disorders; skin disorders |
| 07/01/2004 | US20040126360 Oral formulations for proteins and polypeptides |
| 07/01/2004 | US20040126322 Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
| 07/01/2004 | US20040126319 Screening effect of test agent; forming image; measurement; calibration; quantitative analysis |
| 07/01/2004 | CA2509825A1 Antagonists for human prolactin |
| 07/01/2004 | CA2509665A1 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | CA2509215A1 Method for identifying modulators of human orexin-2 receptor |
| 07/01/2004 | CA2509214A1 Indolizine compounds |
| 07/01/2004 | CA2508825A1 Vaccine for fish cold-water disease |